Literature DB >> 12948010

pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.

Sibylle Neuhoff1, Anna-Lena Ungell, Ismael Zamora, Per Artursson.   

Abstract

PURPOSE: The purpose of this study was to investigate the pH-dependent passive and active transport of weakly basic drugs across the human intestinal epithelium.
METHODS: The bidirectional pH-dependent transport of weak bases was studied in Caco-2 cell monolayers in the physiologic pH range of the gastrointestinal tract.
RESULTS: A net secretion of atenolol and metoprolol was observed when a pH gradient was applied. However, the bidirectional transport of both compounds was equal in the nongradient system. Hence, at lower apical than basolateral pH a change in passive transport caused by an imbalance in the concentration of the uncharged drug species resulted in a "false" asymmetry (efflux ratio). Furthermore, a mixture of pH-dependent passive and active efflux was found for the P-glycoprotein (P-gp, MDR1, ABCB1) substrates, talinolol and quinidine, but not for the neutral drug, digoxin. However, the clinically important digoxin-quinidine interaction depended on the presence of a pH gradient. Hence, the degree of interaction depends on the amount of quinidine available at the binding site of the P-gp.
CONCLUSIONS: Active efflux of weak bases can only be accounted for when the fraction of unionized drug species is equal in all compartments because the transport is biased by a pH-dependent passive component. However, this component may take part in vivo and contribute to drug-drug interactions involving P-gp.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948010     DOI: 10.1023/a:1025032511040

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

1.  An alternative hypothesis to involvement of intestinal P-glycoprotein as the cause for digoxin oral bioavailability enhancement by talinolol.

Authors:  W L Chiou; C Ma; S M Chung; T C Wu
Journal:  Clin Pharmacol Ther       Date:  2001-01       Impact factor: 6.875

2.  Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.

Authors:  Duxin Sun; Hans Lennernas; Lynda S Welage; Jeffery L Barnett; Christopher P Landowski; David Foster; David Fleisher; Kyung-Dall Lee; Gordon L Amidon
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

3.  High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.

Authors:  F Wohnsland; B Faller
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

4.  pH-profile and regional transit times of the normal gut measured by a radiotelemetry device.

Authors:  J Fallingborg; L A Christensen; M Ingeman-Nielsen; B A Jacobsen; K Abildgaard; H H Rasmussen
Journal:  Aliment Pharmacol Ther       Date:  1989-12       Impact factor: 8.171

5.  The absorption of beta-adrenoceptor antagonists in rat in-situ small intestine; the effect of lipophilicity.

Authors:  D C Taylor; R Pownall; W Burke
Journal:  J Pharm Pharmacol       Date:  1985-04       Impact factor: 3.765

6.  GI absorption of beta-lactam antibiotics II: deviation from pH--partition hypothesis in penicillin absorption through in situ and in vitro lipoidal barriers.

Authors:  A Tsuji; E Miyamoto; N Hashimoto; T Yamana
Journal:  J Pharm Sci       Date:  1978-12       Impact factor: 3.534

7.  Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs.

Authors:  K Palm; K Luthman; J Ros; J Grasjo; P Artursson
Journal:  J Pharmacol Exp Ther       Date:  1999-11       Impact factor: 4.030

8.  The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin.

Authors:  I A de Lannoy; M Silverman
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

9.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

Authors:  P Artursson
Journal:  J Pharm Sci       Date:  1990-06       Impact factor: 3.534

10.  Real-time monitoring of P-glycoprotein activation in living cells.

Authors:  Ewa Landwojtowicz; Pierluigi Nervi; Anna Seelig
Journal:  Biochemistry       Date:  2002-06-25       Impact factor: 3.162

View more
  47 in total

Review 1.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

2.  A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration.

Authors:  Xinyuan Zhang; Kerby Shedden; Gus R Rosania
Journal:  Mol Pharm       Date:  2006 Nov-Dec       Impact factor: 4.939

3.  Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

Authors:  Swati Nagar; Richard C Korzekwa; Ken Korzekwa
Journal:  Mol Pharm       Date:  2017-07-31       Impact factor: 4.939

Review 4.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

5.  Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover.

Authors:  Alyscia Cory Severance; Philip J Sandoval; Stephen H Wright
Journal:  J Pharmacol Exp Ther       Date:  2017-06-14       Impact factor: 4.030

6.  Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.

Authors:  Philip J Sandoval; Kimberley M Zorn; Alex M Clark; Sean Ekins; Stephen H Wright
Journal:  Mol Pharmacol       Date:  2018-06-08       Impact factor: 4.436

7.  The asymmetry of the unstirred water layer in permeability experiments.

Authors:  Timo Korjamo; Aki T Heikkinen; Pekka Waltari; Jukka Mönkkönen
Journal:  Pharm Res       Date:  2008-04-16       Impact factor: 4.200

8.  Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling.

Authors:  Xuan Ding; Ivelina Gueorguieva; James A Wesley; Lee J Burns; Carrie A Coutant
Journal:  AAPS J       Date:  2015-07-01       Impact factor: 4.009

9.  Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.

Authors:  Tuba Incecayir; Yasuhiro Tsume; Gordon L Amidon
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

10.  Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein.

Authors:  Mouna Kanaan; Youssef Daali; Pierre Dayer; Jules Desmeules
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-05-26       Impact factor: 4.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.